跳至主要内容
临床试验/IRCT20201116049408N1
IRCT20201116049408N1招募中2 期

Comparing the effects of once versus twice intracoronary injection of allogenic Wharton's jelly derived mesenchymal stem cell in improving ejection fraction of patients with post myocardial infarction moderate to severe reduced ejection fraction

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Ages20- 60 Years
  • Genders: Both
  • First MI within 3 to 5 days
  • Post AMI LVEF less than 40% as assessed by echocardiography
  • Negative pregnancy test ( in women with childbearing potential )

排除标准

  • History of prior anterior myocardial infarction
  • Patients with regional wall motion abnormalities in the non-infarct region
  • Patients with significant valve disease; defined as stenosis or regurgitation graded as greater than moderate (2+)
  • Patients with another etiology of LV dysfunction (known/suspected non ischemic cardiomyopathy, previous anthracycline therapy, known ethanol abuse (greater than 6 oz. ethanol/day on a regular basis).
  • Poor echocardiography window
  • Active infection or history of recurrent infection or positive test for syphilis (RPR), hepatitis B and C (HBsAg, Anti-HCV), HIV and HTLV-1
  • Documental Terminal illness or malignancy
  • Previous bone marrow transplant
  • Autoimmune diseases

研究者

相似试验